anti-S agalactiae humanized monoclonal antibodies (Valneva)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nameanti-S agalactiae humanized monoclonal antibodies (Valneva)
Drug Alias NameGBS antibodies (Intercell)anti-S agalactiae humanized monoclonal antibodies (Intercel)Group B Streptococcus antibodies (Intercell)IC-50
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanizedBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsStreptococcus Agalactiae Infection
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustriaFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIntercell
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVivalis SAIntercell
Active IndicationsN/A
Inactive IndicationsStreptococcus Agalactiae Infection

Other Information

ATC CodeN/A
Related LinksN/A